Cagrilintide Satifarm 20 mg SunSci Pharma

Cagrilintide 20 mg for sale in a convenient pen injector is an innovative drug from SunSci Pharmaceutical that opens up new possibilities in the treatment of obesity and diabetes. This drug doesn't just work — it changes the very system that controls appetite and metabolism.
The action of Cagrilintid is based on a unique mechanism associated with the hormone amylin. It is an analogue of natural amylin, which:
Controls appetite. It affects the satiety centres in the brain, creating a lasting feeling of fullness. You think less about food and consume fewer calories.
Slows down digestion. Cagrilintid slows down the emptying of the stomach, allowing you to feel full for longer and avoid sharp spikes in blood sugar levels after eating.
These two key effects ensure stable and effective weight loss, as well as a significant improvement in the glycaemic profile.
Cagrilintid can be used as a standalone solution or in combination with other popular drugs such as semaglutide or tirzepatide. Clinical studies have shown that when used together, a pronounced synergistic effect is achieved:
Body weight. The combination of Cagrilintid and semaglutide reduces weight by 15.6%, while semaglutide alone reduces weight by only 5.1%.
Glycated haemoglobin. The combination reduces HbA1c by 2.2% compared to 1.8% when using semaglutide alone.
It means that Cagrilintid doesn't just add to the effect of other drugs, it actually makes them work better, making the treatment way more effective.
Who is Cagrilintide good for:
people who are overweight and want to effectively control their appetite;
patients with type 2 diabetes (including in combination with GLP-1 receptor agonists);
patients with type 1 diabetes and excess weight.
Important: before starting the course, be sure to consult your doctor, as the drug has a number of contraindications.
The product is available in a pen-style syringe, which ensures accurate dosing and ease of use.
How to use:
initial dose: 1 mg subcutaneously once a week;
dose increase: the dose may be increased by 1 mg weekly if it is necessary to enhance the effect;
maximum dose: 6 mg per week;
injection site: abdomen, thigh or shoulder.
We offer only original Cagrilintide Satifarm pen 20 mg from SunSci Pharmaceutical with delivery throughout Ukraine. Our team is always ready to provide professional advice so that you can confidently and safely start your journey to health.
Take control of your own health. With Cagrilintide, it will be easier than ever.
No questions about this product, be the first and ask your question.